成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Pharmaceutical intermediates>Bulk Drug Intermediates>2,2-Dimethylpropanethioamide
2,2-Dimethylpropanethioamide
  • 2,2-Dimethylpropanethioamide

2,2-Dimethylpropanethioamide NEW

Price Get Latest Price
Package 1kg 5kg 25kg
Min. Order: 1kg
Supply Ability: 20000
Update Time: 2024-12-23

Product Details

Product Name: 2,2-Dimethylpropanethioamide CAS No.: 630-22-8
Min. Order: 1kg Purity: 99.0%
Supply Ability: 20000 Release date: 2024/12/23

The compound 2,2,2-Trimethylthioacetamide, also known as 2,2-Dimethylpropanethioamide, serves as an intermediate in the synthesis of Dabrafenib. Our company possesses the capability for commercial production and maintains a regular stock of 10 kilograms. Dabrafenib mesylate is commonly formulated into tablets and prescribed for patients with unresectable or metastatic melanoma harboring BRAF V600E or V600K mutations. In cases where the mutation is V600K and surgical removal is not feasible or has resulted in spread, combination therapy with trametinib should be considered.


Company Profile Introduction

Enki Biopharmaceuticals (shanghai) Limited. is a cutting-edge pharmaceutical company committed to the comprehensive exploration, development, manufacturing, and commercialization of top-tier pharmaceutical products. The company established its state-of-the-art technology research and development center in Suzhou City, Jiangsu Province in 2016 and possesses production facilities located in Sichuan Province and Hunan Province. Enki Biopharma is propelled by technological research and development, with a primary focus on the R&D and production of high value-added and high-tech pharmaceutical intermediates/chiral compounds. The ultimate objective is to achieve industrialization through the creation of active pharmaceutical ingredients (APIs), while concurrently establishing core competencies in chiral synthesis, chemical/enzymatic catalysis, and clean production processes. The products primarily target premium foreign markets while simultaneously serving as intermediate support for domestic API production. Enki Biopharma embraces a market-oriented business philosophy, with innovation support and industrialization as its ultimate goals. It upholds the corporate spirit of focus, expertise, innovation, and win-win situations while remaining committed to the mission of creating value for customers, providing opportunities for employees, and promoting human health. Our utmost dedication lies in delivering high-quality products and premium services to our esteemed customers in order to achieve mutual success together. Simultaneously, we strive to foster employee development and promote social harmony.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1kg
VIP4Y
WUHAN FORTUNA CHEMICAL CO., LTD
2024-07-29
$0.00/1kg
VIP6Y
Zison Pharmaceutical (Shandong) Co., Ltd.
2024-05-24
$50.00/1kg
Ouhuang Engineering Materials (Hubei) Co., Ltd
2024-04-23
$6.00/1KG
VIP2Y
Henan Fengda Chemical Co., Ltd
2024-03-22
$80.00/1kg
VIP2Y
Zibo Hangyu Biotechnology Development Co., Ltd
2023-10-30
$0.00/25KG
VIP5Y
Hebei Mojin Biotechnology Co., Ltd
2023-07-28
$10.00/1KG
VIP6Y
Hebei Weibang Biotechnology Co., Ltd
2023-04-28
$0.00/1kg
VIP3Y
Henan Aochuang Chemical Co.,Ltd.
2022-09-30
$0.00/1KG
Jinan Ande Pharmaceutical Co.,Ltd.
2021-12-20
$0.10/1KG
VIP6Y
Shaanxi Dideu Medichem Co. Ltd
2020-04-27
  • Since: 2014-09-10
  • Address: Room 708, Building B(No. 2), No.125 Laiting South Road, Songjiang District, Shanghai,China
INQUIRY